| dc.contributor.author | Dogansen, Sema Ciftci | |
| dc.contributor.author | Yarman, Sema | |
| dc.contributor.author | Yalin, Gulsah Yenidunya | |
| dc.date.accessioned | 2021-03-05T17:31:30Z | |
| dc.date.available | 2021-03-05T17:31:30Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Dogansen S. C. , Yalin G. Y. , Yarman S., "Assessment of macroprolactinemia inpatients with prolactinoma", TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.43, ss.71-75, 2018 | |
| dc.identifier.issn | 0250-4685 | |
| dc.identifier.other | av_c5faa1ed-5055-4db0-a4b6-2ad4bcba5665 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/131266 | |
| dc.identifier.uri | https://doi.org/10.1515/tjb-2017-0062 | |
| dc.description.abstract | Purpose: Macroprolactin, the high-molecular mass prolactin isoform, is considered to be an inactive product with extrapituitary origin. Although macroprolactinemia is considered a benign condition, there is evidence of overlapping clinical features among patients with hyperprolactinemia. Data on the prevalence of macroprolactinemia in prolactinomas is also quite limited. The aim of this study was to assess the prevalence of macroprolactinemia in our patients with prolactinoma. | |
| dc.language.iso | eng | |
| dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
| dc.subject | Moleküler Biyoloji ve Genetik | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Moleküler Biyoloji ve Genetik | |
| dc.subject | Sitogenetik | |
| dc.subject | Temel Bilimler | |
| dc.title | Assessment of macroprolactinemia inpatients with prolactinoma | |
| dc.type | Makale | |
| dc.relation.journal | TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 43 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 71 | |
| dc.identifier.endpage | 75 | |
| dc.contributor.firstauthorID | 251116 | |
